Eli Lilly Corp. buy BMO Capital Markets
Start price
07.02.24
/
50%
€666.00
Target price
07.02.25
€802.46
Performance (%)
11.02%
Price
02.08.24
€737.00
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets currently has a performance of 11.02%. A total of €2.41 was paid as dividends for this prediction. This prediction currently runs until 07.02.25. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Eli Lilly Corp. | -0.607% | -0.607% |
iShares Core DAX® | -3.935% | -2.628% |
iShares Nasdaq 100 | -3.608% | -9.283% |
iShares Nikkei 225® | -4.513% | -6.951% |
iShares S&P 500 | -2.607% | -4.402% |
Comments by BMO_Capital_Markets for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at BMO Capital Markets from $710.00 to $865.00. They now have an "outperform" rating on the stock.
Ratings data for LLY provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€842.00
03.07.24
03.07.24
€928.23
03.07.25
03.07.25
-12.47%
02.08.24
02.08.24